Drug Licence in India 2026

If you are setting up a pharmacy, medical store, wholesale drug distribution business, or a healthcare clinic that stocks and sells medicines in India, you are legally required to hold a Drug Licence before you dispense a single strip. Operating without one is a punishable offence under the Drugs and Cosmetics Act 1940, with penalties that include imprisonment of up to three years and fines under section 27. The licence is not optional overhead, it is the operating permit that validates your entire business. In 2026, the Drugs Controller General of India (DCGI) and respective State Drugs Controllers have streamlined submissions through state-specific portals and the CDSCOOw portal, but the physical inspection, documentation standards, and compliance thresholds have only tightened, especially for stores near educational institutions under Rule 53 of the Drugs and Cosmetics Rules 1945. KAMRIT Financial Services LLP manages the complete end-to-end process for your Drug Licence, from eligibility assessment and document collation through State Drugs Controller application submission, follow-up, inspection coordination, and final licence certificate delivery. We handle the paperwork, follow up with the regulatory office, and keep you informed at every stage so you can focus on setting up your business.

What is Drug Licence in India 2026?

A Drug Licence is a statutory permission granted by the State Drugs Controller (or the Drugs Controller General of India at the central level) authorising an entity to manufacture, sell, or distribute drugs and cosmetics in India. It derives its legal force from the Drugs and Cosmetics Act 1940 (Act 23 of 1940) and the Drugs and Cosmetics Rules 1945 framed thereunder. The Act defines a 'drug' broadly to include medicines as defined under the Drugs and Magic Remedies Act, as well as cosmetics. There are distinct licence categories: a Retail Drug Licence (RDL / Form 19) for running a pharmacy or medical store selling to end consumers; a Wholesale Drug Licence (WDL / Form 20) for businesses distributing medicines to retailers and hospitals; and specialised Manufacturing Licences (Form 25, Form 26, Form 28, Form 28A) for drug production units regulated by the CDSCO at the central level and State Drugs Controllers at the state level. The appropriate licence class depends on your business model. The State Drugs Controller of the relevant state where your premises are located is the issuing and inspecting authority for retail and wholesale licences. For loan licences or third-party manufacturing, additional conditions under Schedule K of the Rules apply.

Who needs this

Eligibility for a Drug Licence is governed by the Drugs and Cosmetics Rules 1945, with conditions that vary by licence category. KAMRIT assesses your specific situation against these criteria before filing.

• The applicant must be a natural person, partnership firm, LLP, company, or society lawfully constituted in India.
• For a Retail Drug Licence (Form 19), the premises must have a minimum enclosed area of 150 square feet in a city and 120 square feet outside a city, with adequate lighting, ventilation, and storage conditions.
• For a Wholesale Drug Licence (Form 20), the premises must have a minimum enclosed area of 250 square feet with separate storage for recalled or expired drugs.
• The business must be either owned or managed by a registered pharmacist holding a current registration with the State Pharmacy Council, proof of valid registration certificate is mandatory.
• For Retail Drug Licence, at least one registered pharmacist must be physically present during all business hours. Self-declaration of availability is not sufficient.
• The premises must not be located within 25 metres of a primary, secondary, or senior secondary school as per the Drugs and Cosmetics Rules 1945, Rule 53(5).
• If applying under the New Drug Approval process or for schedule drugs (Schedule H, H1, or X), additional compliance conditions under the respective schedules apply.
• For wholesale of psychotropic substances under the NDPS Act 1985, a separate Narcotics Permit is required in addition to the Drug Licence.
• The premises must have a functional refrigerator for temperature-sensitive drugs and documented cold chain records.
• All drugs in stock must be traceable to purchase invoices that satisfy the requirements of the Drugs and Cosmetics Act and the Jan Vishwas Act provisions on traceability.

Documents required

The State Drugs Controller inspects your application against the Drugs and Cosmetics Rules 1945 before granting a licence. A complete document package accelerates the inspection and reduces queries.

• Application in Form 19 (Retail) or Form 20 (Wholesale), signed by the applicant and the responsible pharmacist.
• Plan of the premises drawn to scale with dimensions annotated, showing storage zones, dispensing counter, and pharmacist workspace.
• Proof of premises ownership or registered Rent Agreement with valid address proof (registered lease or sale deed).
• Photographs and PAN card of the applicant (proprietor, partner, director, or authorised signatory).
• Photographs and PAN card of the registered pharmacist, along with a valid State Pharmacy Council registration certificate and an experience affidavit.
• Partnership Deed or Certificate of Incorporation and MOA/AOA (for companies and LLPs), as applicable.
• NOC from the landlord (Form 10 or stamped letter) if premises are leased, confirming no objection to drug storage.
• Proof of premises classification as commercial or institutional use, property tax receipt, electricity bill in business name, or municipal trade licence.
• Challan or Demand Draft evidencing government fee payment. Government fees are typically Rs. 3,000 per year for a Retail Licence and Rs. 5,000 per year for a Wholesale Licence, varying by state.
• GST Registration Certificate (mandatory since July 2017 under the CGST Act 2017).
• Details of drugs proposed to be sold, with supporting technical information for schedule drugs (Schedules H, H1, or X).
• Fire safety compliance certificate or No Objection Certificate from the local fire department, required in several states including Maharashtra, Gujarat, and Karnataka.

How KAMRIT runs it, step by step

KAMRIT maps every stage of the Drug Licence process against the requirements of the Drugs and Cosmetics Act 1940, Rules 1945, and the applicable state drugs control portal. Here is how we take your filing from zero to licence.

1. Eligibility and Premises Assessment. KAMRIT begins by reviewing your proposed business activity, licence category (retail or wholesale), and premises address against the eligibility criteria under the Drugs and Cosmetics Rules 1945, including the mandatory 25-metre distance rule from educational institutions. We assess pharmacist availability, area measurements, and premises zoning. If your premises fails the pre-assessment, we identify alternatives before you commit to a lease.
2. Document Collation and Legal Review. We compile all documents listed in the applicable section above. For companies and LLPs, we verify the MOA/AOA to confirm drug or pharmaceutical trading is authorised under the object clause, a common rejection reason under section 6 of the Companies Act 2013. We also verify the pharmacist's State Pharmacy Council registration is current and has not been suspended or cancelled.
3. Application Filing with State Drugs Controller. KAMRIT prepares and submits the application in Form 19 (Retail) or Form 20 (Wholesale) to the relevant State Drugs Controller along with the government fee challan. In states with online portals (Maharashtra SUGAM portal, Karnataka online drug licence portal, Tamil Nadu drug licence portal), we file electronically and generate the file number. In other states, we file physically and obtain an official diary number.
4. Inspection Scheduling and Coordination. The State Drugs Controller schedules a physical inspection of the premises by a Drug Inspector under Rule 51 of the Drugs and Cosmetics Rules 1945. KAMRIT coordinates the inspection date, ensures the premises is inspection-ready (stock organised, pharmacist available, storage conditions documented), and accompanies the inspection where possible. The inspector files a report within 30 days of inspection under Rule 51(4).
5. Query Resolution and Compliance Replies. If the Drug Inspector raises objections or the reviewing officer requests additional documents, KAMRIT prepares and submits the compliance reply within the stipulated period. Common objections include insufficient floor area, absence of pharmacist at the time of inspection, and incomplete premises plans. Our team resolves these within 5 to 10 working days of receiving the query.
6. Licence Grant and Certificate Collection. Once the inspection report is satisfactory, the State Drugs Controller issues the Drug Licence. KAMRIT collects the licence certificate or authorises courier delivery. The licence is typically valid for a period of 5 years and is renewable 90 days before expiry under Rule 53(8) of the Drugs and Cosmetics Rules 1945.

Timeline

From the date KAMRIT receives a complete document package and the premises has passed pre-assessment, the process timeline breaks into two phases. The KAMRIT-controlled phase, covering document review, application preparation, submission, and inspection coordination, typically takes 2 to 3 weeks. The regulator-controlled phase, from submission to inspection scheduling and final licence grant, varies significantly by state. States with online portals and streamlined processes such as Maharashtra, Karnataka, and Gujarat typically grant the licence within 4 to 8 weeks after submission, making an end-to-end timeline of 6 to 10 weeks realistic. States with slower processing such as Uttar Pradesh, Bihar, and West Bengal may take 10 to 16 weeks. The inspection itself is typically scheduled within 15 to 30 days of application submission, but the Inspector's report review and senior officer sign-off can add another 4 to 8 weeks. KAMRIT tracks every regulator-controlled milestone through direct liaison with the drug control office, reducing the silent waiting periods that inflate timelines at most other service providers.

How our pricing compares

KAMRIT's Drug Licence service starts at Rs. 6,899 for standard retail or wholesale filings. This package covers document review, application preparation and submission, government fee payment assistance, inspection coordination, and post-inspection compliance follow-up. It does not include government licence fees (Rs. 3,000 to Rs. 5,000 per annum depending on state and category), stamp duty where applicable, courier charges, or additional certifications such as the fire NOC. IndiaFilings quotes Rs. 8,999 to Rs. 14,999 for a Drug Licence and typically subcontracts the inspection coordination to local associates, adding turnaround time. Vakilsearch quotes Rs. 9,499 to Rs. 16,999 with a base package that often excludes post-inspection query resolution, a stage where 30 to 40 percent of applications face objections. ClearTax focuses primarily on GST and income tax filings; their Drug Licence service is offered through a partner network at Rs. 9,999 with limited state-specific expertise. LegalRaasta offers Drug Licence filings at Rs. 7,499 to Rs. 12,999 but with turnaround times of 12 to 20 weeks in non-metro states due to limited inspector liaison networks. KAMRIT's Rs. 6,899 price point includes active inspector liaison, not passive tracking, and our team has direct working relationships with drug control offices in Maharashtra, Karnataka, Gujarat, Delhi-NCR, Tamil Nadu, and Kerala. We believe our price is justified because we do not hide the inspection coordination cost, we do not subcontract the regulatory follow-up, and our in-house compliance team resolves objections without escalating charges.

Common mistakes KAMRIT avoids

KAMRIT has processed Drug Licence applications across more than a dozen states. The following mistakes account for the majority of rejections, delays, and second-time applications that we subsequently fix.

• Applying for a Retail Licence (Form 19) when the business model is wholesale, this triggers a separate WDL requirement under Rule 61 of the Drugs and Cosmetics Rules 1945 and results in dual filings.
• Signing the Form 19 or Form 20 application by a non-pharmacist. The Drugs and Cosmetics Rules 1945 require the responsible pharmacist to countersign or be named as the responsible person at the premises.
• Submitting a premises plan without dimension annotations or without showing the pharmacist's counter, storage racks, and refrigeration area, a common grounds for inspection failure.
• Overlooking the 25-metre rule for premises located near a school, college, or coaching centre. This is non-waivable under Rule 53(5) of the Drugs and Cosmetics Rules 1945 in most states including Delhi and Maharashtra.
• Failing to verify the pharmacist's State Pharmacy Council registration is current. A cancelled or lapsed registration invalidates the entire application even if the pharmacist is physically present.
• Not obtaining the GST registration before filing the drug licence application. Several states, including Karnataka and Maharashtra, reject applications without a valid GSTIN.
• Assuming the licence is valid pan-India. A Drug Licence issued by a State Drugs Controller applies within that state only. Multi-state distribution requires separate WDL filings in each state.
• Not renewing the licence 90 days before expiry. Late renewal triggers a fresh application process, government penalty fees, and a period of non-compliance, during which the premises cannot legally store or sell drugs.